Acro Biomedical (ACBM) Interest Expenses (2018 - 2025)

Acro Biomedical's Interest Expenses history runs 8 years deep, the most recent figure standing at $2710.0 for Q3 2025.

• In Q3 2025, Interest Expenses rose 141.32% year-over-year to $2710.0; the TTM figure through Dec 2025 stood at $6025.0 (up 38.86% YoY), while the FY2024 annual figure was $4339.0, up 35.34% from the prior year.
• Interest Expenses was $2710.0 for Q3 2025 at Acro Biomedical, up from $1948.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $2710.0 in Q3 2025 to a low of -$3155.0 in Q4 2021.
• Historically, Interest Expenses has averaged $851.0 across 5 years, with a median of $839.0 in 2023.
• The sharpest annual moves came in 2021 and 2022: Interest Expenses surged 467.57% in 2021, then plunged 91.65% in 2022.
• A 5-year view of Interest Expenses shows it stood at -$3155.0 in 2021, then surged by 124.94% to $787.0 in 2022, then rose by 6.61% to $839.0 in 2023, then soared by 43.62% to $1205.0 in 2024, then jumped by 124.9% to $2710.0 in 2025.
• The last three Interest Expenses figures came in at $2710.0 (Q3 2025), $1948.0 (Q2 2025), and $1367.0 (Q1 2025), per Business Quant data.